share_log

博腾股份(300363.SZ)：能够为小分子药物、大分子药物及基因细胞治疗等不同类型的药物及疗法提供CDMO服务

Boteng Co., Ltd. (300363.SZ): Can provide CDMO services for different types of drugs and therapies such as small molecule drugs, large molecule drugs, and gene cell therapy

Gelonghui Finance ·  May 10 05:01

Gelonghui, May 10 | Boteng Co., Ltd. (300363.SZ) said on the investor interactive platform that the company is a pharmaceutical R&D and production outsourcing organization (CDMO) that provides full-category, end-to-end services for pharmaceutical companies, biotechnology companies, scientific research institutions, etc. on a global scale, and can provide CDMO services for different types of drugs and therapies such as small molecule drugs, large molecule drugs, and gene cell therapy. The company continues to invest in R&D resources to establish an innovative technology platform covering drug crystallization, biocatalysis, fluid chemistry, micropowder, highly active drugs, preparation chromatography, fluorine chemistry, photochemistry, metal catalysis, oral formulation platforms, highly active formulation platforms, insoluble drug technology platforms, sterile formulation platforms, topical topical formulation platforms, lentivirus production platforms, SF9 and HEK293 production process platforms, etc., covering the technical needs of different customer projects.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment